IT Pro is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more

Qlarity Imaging teams with Blackford to improve breast MRI accuracy

Qlairty will merge its AI-powered diagnostic software with Blackford’s centralized imaging platform

Woman talking with a nurse while sitting on a table for an MRI machine

Qlarity Imaging and Blackford have signed a new pact to improve breast magnetic resonance imaging (MRI) accuracy.

QuantX by Qlarity Imaging differentiates benign from malignant breast lesions by synthesizing 34 radiomic features into a single value. The QuantX Score, derived from analysis of proven lesions, indicates the likelihood of malignancy in a specimen. The FDA-cleared artificial intelligence (AI) also assists radiologists with volumetric and surface area measurements.

Per the new deal, Qlarity will integrate its AI diagnostic software with Blackford’s centralized imaging platform to help radiologists and health care systems achieve better clinical outcomes.

The Qlarity-Blackford partnership is also geared toward reducing breast MRI deployment time, costs, maintenance, monitoring, and support requirements.

"Breast MRI evaluations are one of the more difficult exams for radiologists. Factoring in the current challenges contributing to widespread radiologist burnout, the question is not if technological advancements are needed, but how they can be developed and implemented to add the most value," said Jon DeVries, Qlarity Imaging CEO

DeVries added, "Partnering with Blackford will help radiologists and their teams overcome current workflow, budget, and productivity challenges, while also providing unique opportunities for innovation with partners to improve the quality of breast cancer screening and diagnosis strategies."

Related Resource

Preparing for AI-enabled cyber attacks

MIT technology review insights

AI icon against a laptop icon on a yellow background - whitepaper from DarktraceDownload now

Commenting on its tool’s scope, Qlarity stated QuantX is designed for screening patients at high risk for breast abnormalities. QuantX's clinical trials that earned it FDA approval found it reduced missed cancers by 39% and increased clinical accuracy by 20%.

QuantX is not intended for the primary interpretation of digital mammograms. 

"We are delighted that Qlarity's QuantX™ will be available through Blackford's curated marketplace of applications. We look forward to working with Qlarity to provide our customers and channel partners with simplified access to QuantX™ through our dedicated platform, to help drive additional clinical value for patients," said Ben Panter, Blackford Analysis CEO. 

Featured Resources

Join the 90% of enterprises accelerating to the cloud

Business transformation through digital modernisation

Free Download

Delivering on demand: Momentum builds toward flexible IT

A modern digital workplace strategy

Free download

Modernise the workforce experience

Actionable insights and an optimised experience for both IT and end users

Free Download

The digital workplace roadmap

A leader's guide to strategy and success

Free Download

Recommended

Protecting healthcare from cybercrime
Whitepaper

Protecting healthcare from cybercrime

25 May 2022
Recommendations for managing AI risks
Whitepaper

Recommendations for managing AI risks

25 Apr 2022
Recommendations for managing AI risks
Whitepaper

Recommendations for managing AI risks

25 Apr 2022
BangDB now offers its AI and graph data platform on cloud
artificial intelligence (AI)

BangDB now offers its AI and graph data platform on cloud

19 Apr 2022

Most Popular

Raspberry Pi launches next-gen Pico W microcontroller with networking support
Hardware

Raspberry Pi launches next-gen Pico W microcontroller with networking support

1 Jul 2022
Universities are fighting a cyber security war on multiple fronts
cyber security

Universities are fighting a cyber security war on multiple fronts

4 Jul 2022
Hackers claim to steal personal data of over a billion people in China
data breaches

Hackers claim to steal personal data of over a billion people in China

4 Jul 2022